Correlation Between PDS Biotechnology and Cardiff Oncology
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Cardiff Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Cardiff Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Cardiff Oncology, you can compare the effects of market volatilities on PDS Biotechnology and Cardiff Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Cardiff Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Cardiff Oncology.
Diversification Opportunities for PDS Biotechnology and Cardiff Oncology
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between PDS and Cardiff is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Cardiff Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiff Oncology and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Cardiff Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiff Oncology has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Cardiff Oncology go up and down completely randomly.
Pair Corralation between PDS Biotechnology and Cardiff Oncology
Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the Cardiff Oncology. But the stock apears to be less risky and, when comparing its historical volatility, PDS Biotechnology Corp is 1.4 times less risky than Cardiff Oncology. The stock trades about -0.27 of its potential returns per unit of risk. The Cardiff Oncology is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest 321.00 in Cardiff Oncology on September 2, 2024 and sell it today you would lose (60.00) from holding Cardiff Oncology or give up 18.69% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
PDS Biotechnology Corp vs. Cardiff Oncology
Performance |
| Timeline |
| PDS Biotechnology Corp |
| Cardiff Oncology |
PDS Biotechnology and Cardiff Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PDS Biotechnology and Cardiff Oncology
The main advantage of trading using opposite PDS Biotechnology and Cardiff Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Cardiff Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiff Oncology will offset losses from the drop in Cardiff Oncology's long position.| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
| Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. PDS Biotechnology Corp | Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. Eyenovia |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |